Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Biomarker Insights
|
September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation
Philip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
RMD Open
|
March 4, 2026
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study
Peter C Taylor, Georg Schett, Tom W J Huizinga, et al.
The Journal of Allergy and Clinical Immunology
|
January 17, 2017
Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients
Philip E Silkoff, Michel Laviolette, Dave Singh, et al.
Respiratory Research
|
April 25, 2016
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study
P E Silkoff, M Laviolette, D Singh, et al.
Development (Cambridge, England)
|
July 11, 2015
Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis
Nanbing Li-Villarreal, Meredyth M Forbes, Andrew J Loza, et al.
Development (Cambridge, England)
|
April 30, 2016
Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis
Nanbing Li-Villarreal, Meredyth M Forbes, Andrew J Loza, et al.
Nature Communications
|
June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Megan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
Matteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
Cell Reports
|
January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development
Xianmin Luo, Yujie Fu, Andrew J Loza, et al.
RMD Open
|
June 28, 2024
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
Peter C Taylor, Georg Schett, Tom Wj Huizinga, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Biomarker Insights
|
September 30, 2017
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation
Philip E Silkoff, Dave Singh, J Mark FitzGerald, et al.
RMD Open
|
March 4, 2026
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study
Peter C Taylor, Georg Schett, Tom W J Huizinga, et al.
The Journal of Allergy and Clinical Immunology
|
January 17, 2017
Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients
Philip E Silkoff, Michel Laviolette, Dave Singh, et al.
Respiratory Research
|
April 25, 2016
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study
P E Silkoff, M Laviolette, D Singh, et al.
Development (Cambridge, England)
|
July 11, 2015
Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis
Nanbing Li-Villarreal, Meredyth M Forbes, Andrew J Loza, et al.
Development (Cambridge, England)
|
April 30, 2016
Dachsous1b cadherin regulates actin and microtubule cytoskeleton during early zebrafish embryogenesis
Nanbing Li-Villarreal, Meredyth M Forbes, Andrew J Loza, et al.
Nature Communications
|
June 9, 2016
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Megan K Ruhland, Andrew J Loza, Aude-Helene Capietto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus
Matteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
Cell Reports
|
January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development
Xianmin Luo, Yujie Fu, Andrew J Loza, et al.
RMD Open
|
June 28, 2024
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
Peter C Taylor, Georg Schett, Tom Wj Huizinga, et al.
Page
of 12